可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commum, 1998,251(2): 471-476.
[2]Lee DK, Cheng R, Nguyen T, et al. Characterization of Apelin, the ligand for the APJ receptor[J]. J Neurochem, 2000, 74(1): 34-41.
[3]Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope Apelin in human cardiac dysfunction[J]. Circulation, 2003,108(12): 1432-1439.
[4]Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility[J]. Circ Res, 2002,91(5): 434-440.
[5]Tatemoto K, Takayama K, Zou MX, et al. The novel peptide Apelin lowers blood pressure via a nitric oxidedependent mechanism[J]. Regul Pept, 2001,99(2-3): 87-92.
[6]Foldes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of Apelin,the novel ligand of the orphan receptor APJ, in patients with heart failure[J]. Biochem Biophys Res Commun, 2003,308(3): 480-485.
[7]Zhan CD,Wang TH,Pan JY. The role of nitric oxide in the angiotensin IIinduced hypertrophy of cardiac myocytes[J] . Sheng Li Xue Bao, 1999,51(6): 660-666.
[8]ScherrerCrosbie M, Ullrich R, Bloch KD, et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice[J]. Circulation,2001,104(11): 1286-1291.
[9]Seki T, Hagiwara H, Naruse K, et al. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes[J]. Biochem Biophys Res Commun, 1996,218(2):601–605.